All
Finally, good news for triple negative breast cancer patients!
Kids kick cancer with martial arts and karate program
Got cancer? Blame it on Drew's cancer
Cancer Treatment Gets Personal
Recent cancer research has been able to allow doctors to know what treatments work in certain patients—and what treatment don’t.
Fundraiser this weekend to help a sick dog
PARP inhibitors create buzz at ASCO
Update from ASCO: Personalizing breast cancer treatment
Young, in love, and diagnosed
Testing for HER2 Overexpression in Breast Cancer
Testing for HER2 overexpression in breast cancer can affect treatment decisions.
Avastin Falls Short in Early-Stage Colon Cancer
Adding Avastin (bevacizumab) to standard chemotherapy after surgery failed to extend the time early-stage colon cancer patients were free of recurrence.
New Test Predicts Colon Cancer Recurrence
For the first time, a test can predict which patients with stage 2 colon cancer are more likely to have a recurrence.
Avastin Successful With Various Chemotherapies in Breast Cancer
Adding Avastin to standard therapy delays progression of advanced HER2-negative breast cancer in women without prior treatment.
Trial Confirms Benefit of Targeted Combination in Lung Cancer
A large phase III study examining whether the addition of Tarceva (erlotinib) to Avastin (bevacizumab) delayed progression of advanced non-small cell lung cancer reached its primary goal.
CA-125 Monitoring Not Helpful for Ovarian Cancer Survivors
Results from an international study challenge current practice of screening for ovarian cancer relapse.
Therapeutic Vaccine Delays Lymphoma Recurrence
Researchers of a follicular lymphoma trial hope that BiovaxID, a personalized vaccine, could help delay recurrences.
Herceptin Improves Survival in Gastric Cancer
The breast cancer drug Herceptin (trastuzumab) extends survival in certain gastric cancer patients by almost three months, according to a phase III international study.
Antidepressants Reduce the Effectiveness of Tamoxifen
Taking tamoxifen at the same time as certain drugs that treat depression and hot flashes may reduce the cancer drug’s ability to prevent breast cancer recurrence.
Zactima Delays Advanced Lung Cancer Growth
An international phase III trial found the investigational lung cancer drug, Zactima (vandetanib), significantly slowed the time a patient’s advanced lung cancer progressed.
PARP Inhibitors Successful Against Hard-to-Treat Breast Cancers
A new class of drugs called PARP inhibitors is getting some serious attention in metastatic triple-negative breast cancers.
What's your exercise excuse?
How do we improve cancer clinical trial participation?
FDA approves the first cancer drug for dogs
Riding with Amazons
Study shows how to prevent rash from EGFR inhibitors
New site can help you find the financial assistance you need
Chemobrain research and attention growing
Olivia Newton-John wants to sing your song
Why aren't cancer docs talking to their patients about fertility?
A new test can predict risk of colon cancer recurrence
Ginger offers relief for chemo-related nausea